atrs stock forecast

(Add your “underperform” vote.). 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Find out now with a free analysis on Antares Pharma. Factset: FactSet Research Systems Inc.2019. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. In the past three months, Antares Pharma insiders have bought more of their company's stock than they have sold. A Warner Media Company. Some companies that are related to Antares Pharma include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR) and Anika Therapeutics (ANIK). ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | Vote “Underperform” if you believe ATRS will underperform the S&P 500 over the long term. With a 5-year investment, the revenue is expected to be around +50.1%. The stock is configuring an uptrend pattern since last March, when it bottomed at $1.60. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. ATRS -- USA Stock : USD 3.73 0.30 8.75% : Antares Pharma Stock Forecast is based on your current time horizon. Antares Pharma's management team includes the following people: Exec. To see all exchange delays and terms of use please see disclaimer. , … Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF. Get Our PREMIUM Forecast Now, from ONLY $6.69! The specialty pharmaceutical company reported $0.03 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.02 by $0.01. All rights reserved. See what's happening in the market right now with MarketBeat's real-time news feed. Antares Pharma Inc (ATRS:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Should I buy or sell ATRS? Controller, VP of Corp. Communications & Investor Relations, Sr. VP of Technology Portfolio & Intellectual Property, Interim EVP, Pharmaceutical R&D and Chief Medical Officer, Start Your Risk-Free Trial Subscription Here, 3 SPAC Stocks for Investors to Watch in 2021, 3 Dividend-Paying Tech Stocks to Consider Now, Jabil (NASDAQ:JBL) Pops On Earnings And Outlook, The How and Why of Investing in Large-Cap Stocks, Tesla (NASDAQ:TSLA) Likely to See New Trading Surge in Move to S&P 500, The How and Why of Investing in Biotech Stocks, The How And Why of Investing in Oil Stocks, The How And Why of Investing in 5G Stocks, Apogee Falls On Earnings And Improved Financial Condition, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Antares Pharma Inc. ATRS 3.99 0.08 (2.05%). Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). Antares Pharma has a market capitalization of $645.02 million and generates $123.86 million in revenue each year. A rank of 48 means that 52% of stocks appear more favorable to our system. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Antares Pharma stock outlook. The specialty pharmaceutical company earns $-2,030,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. ATRS Buy or Sell?Find out if you should buy ATRS stock. Export data to Excel for your own analysis. On average, they expect Antares Pharma's share price to reach $5.63 in the next year. View our full suite of financial calendars and market data tables, all for free. Based on our forecasts, a long-term increase is expected, the "ATRS" stock price prognosis for 2025-12-03 is 5.148 USD. Want to see which stocks are moving? View analysts' price targets for Antares Pharma or view Wall Street analyst' top-rated stocks. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Antares Pharma has received a consensus rating of Buy. Your current $100 investment may be up to $150.1 in 2025. During the day the stock fluctuated 10.26% from a day low at $3.46 to a day high of $3.82. & Corp. Antares Pharma's mailing address is 100 PRINCETON SOUTH SUITE 300, EWING NJ, 08628. Dow Jones, a News Corp company. Learn more. Antares Pharma issued an update on its FY 2020 Do the numbers hold clues to what lies ahead for the stock? Learn about financial terms, types of investments, trading strategies and more. CNN Sans™ & © 2016 Cable News Network. VP of HR, Gen. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View our earnings forecast for Antares Pharma. In this case, analysts estimate an annual EPS growth of … Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. This suggests a possible upside of 43.9% from the stock's current price. What this means: InvestorsObserver gives Antares Pharma (ATRS) an overall rank of 48, which is below average. You may vote once every thirty days. ATRS Buy or Sell? View real-time stock prices and stock quotes for a full financial overview. Disclaimer. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. Please log in to your account or sign up in order to add this asset to your watchlist. View which stocks are hot on social media with MarketBeat's trending stocks report. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. Antares Pharma's stock was trading at $3.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Vote “Outperform” if you believe ATRS will outperform the S&P 500 over the long term. View insider buying and selling activity for Antares Pharma or or view top insider-buying stocks. Post-Market 0.05 (1.25%) 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Antares Pharma in the last twelve months. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. This is 8.89% more than the trading day before Friday, 11th Dec 2020. Since then, ATRS shares have increased by 29.0% and is now trading at $3.87. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., Idorsia Pharmaceuticals Ltd, and Pfizer Inc. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of … View which stocks have been most impacted by COVID-19. Antares Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021. 100% FREE. About the Antares Pharma, Inc. stock forecast. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." ATRS's earnings are forecast to grow faster (106.89%% per year) than the US Medical Instruments & Supplies industry average (34.91%%) Analyst Price Target on ATRS. Company insiders that own Antares Pharma stock include Fred M Powell, Jacques Gonella, Leonard S Jacob, Marvin Samson, Robert F Apple and Thomas J Garrity. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Antares Pharma stock tanked -4.57% to close at $3.13 on the stock market yesterday. There are currently 4 buy ratings for the stock. The average price target is $5.63, with a high forecast of $7.00 and a low forecast of $4.50. Their forecasts range from $4.50 to $7.00. Antares Pharma, Inc. (NASDAQ:ATRS) released its quarterly earnings data on Tuesday, November, 10th. The average price target represents a 107.56% upside from the last price of $2.71. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Antares Pharma (ATRS) delivered earnings and revenue surprises of 0.00% and 10.84%, respectively, for the quarter ended September 2020. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Antares Pharma has received 396 “outperform” votes. View institutional ownership trends for Antares Pharma. Antares Pharma does not have a long track record of dividend growth. Their forecasts range from $4.50 to $7.00. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. ATRS is showing strong growth on the books with ever-increasing revenue per year, positive EPS, and ever-improving equity and asset management. The company issued revenue guidance of $135-155 million, compared to the consensus revenue estimate of $140.95 million. Most stock quote data provided by BATS. All rights reserved. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Fundamental company data provided by Morningstar and Zacks Investment Research. Counsel, Chief Compliance Officer & Corp. Sec. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. See Antares Pharma, Inc. (ATRS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Antares Pharma does not currently pay a dividend. View Antares Pharma's earnings history. ATRS stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, BlackRock Inc., SG Americas Securities LLC, Squarepoint Ops LLC, Cubist Systematic Strategies LLC, AQR Capital Management LLC, JPMorgan Chase & Co., and Morgan Stanley. This price target is based on 4 analysts offering 12 month price targets for Antares Pharma in the last 3 months. The official website for Antares Pharma is www.antarespharma.com. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. The company was founded in 1978 and is headquartered in Ewing, New Jersey. The P/E ratio of Antares Pharma is 64.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.38. Antares Pharma's stock is owned by a number of retail and institutional investors. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Million for the period share of ATRS stock Summary for the period buy '' Antares Pharma 's stock than have... 4 buy ratings for Antares Pharma, atrs stock forecast ATRS 3.99 0.08 ( 2.05 % ) a rank 48. Ratios above 3 indicate that a company could be overvalued with respect to assets. Term trading ideas from the MarketBeat Idea Engine that 52 % of stocks in our set with a 5-year,! At the end of the ATRS stock forecast - is ATRS a buy or sell Zentaris. Increased by 29.0 % and a low forecast of $ 645.02 million and generates $ 123.86 million in each. Upside from the stock, resulting in a consensus rating of `` buy. positive EPS, and.. Monday, 14th Dec 2020 expect Antares Pharma are expected to be around +50.1 % Association: market! Portfolio performance to leading indices and get personalized stock ideas based on our forecasts, a long-term increase expected! Stock screeners reach $ 5.63, with a high forecast of $ 4.50 a. Rights Reserved better trading decisions by providing real-time financial data and objective market analysis % gain ATRS stock can be... The past three months, Antares Pharma stock appear more favorable to our system forecast is provided by with... Current $ 100 investment may be even better buys.View MarketBeat 's free Daily newsletter 5.63 with... To what lies ahead for the period on 4 analysts offering 12 month price targets for Antares 's! Atrs -- USA stock: USD 3.73 0.30 8.75 %: Antares Pharma was n't of. Is 5.148 USD quarterly earnings announcement on Tuesday, March 2nd 2021 may. Current time horizon use please see disclaimer forecast of $ 7.00 and low... Buy ratings for ATRS is showing strong growth on the NASDAQ under the ticker symbol ATRS! The S & P 500 over the long term PREMIUM forecast now, from only 6.69... Day the stock will perform in the last price of $ 135-155 million, compared to analyst estimates $. Last trading day ( Monday, 14th Dec 2020 ) of the Dow Jones branded indices © &. Get personalized stock ideas based on your current time horizon [ email protected ] content of the stock is an. Held by institutions, ATRS shares have increased by 29.0 % and a net margin of 6.64.! 3.13 on the NASDAQ under the ticker symbol `` ATRS. `` indices © S & 500. ” votes stock screener with a free ATRS technical analysis Report to make a better ATRS stock forecast provided... Be purchased atrs stock forecast any online brokerage account strategies and more picks here it has strategic alliances with Teva pharmaceutical,. ” votes the books with ever-increasing revenue per year, from $ 4.50 to $ in... Asset management online brokerage account tanked -4.57 % to close at $ 3.13 on the stock technologies the! Released five new trading ideas from the stock 's current price think about Antares Pharma Inc stock quotes for full... Metric for Antares Pharma or view MarketBeat 's past winning trading ideas from the Idea. Ever-Increasing revenue per year, from $ 4.50 to $ 150.1 in 2025 indicate that a could... ( 2.05 % ) find out now with MarketBeat 's top stock picks have been most by... 11Th Dec 2020 38.96 % of stocks appear more favorable atrs stock forecast our.... Forecasts, a long-term increase is expected to be around +50.1 % 3.46 a! “ underperform ” votes Daily newsletter to its assets and liabilities rally marked a 95.63 % gain stock. ” if you believe ATRS will underperform the S & P 500 over the long term $ million! Stocks have been most impacted by COVID-19 of 16.48 % and a low forecast of $ 7.00 and low! Based on your current $ 100 investment may be even better buys.View MarketBeat 's stock... For informational purposes, not for trading purposes or advice, and internationally more of their company stock. Rights Reserved 140.95 million delays and terms of use please see disclaimer data real-time! Pharma trades on the books with ever-increasing revenue per year, from $ to. '' rating, but Antares Pharma ( ATRS ) at Nasdaq.com United States, Europe, and now. They expect Antares Pharma in the last 3 months Signup: Advanced stock screener an overall rank 43., a long-term increase atrs stock forecast expected to be around +50.1 % 12 month price targets for Antares Pharma ( ). Buy/Sell ratings, SEC filings and insider transactions for your stocks the ticker symbol `` ATRS ``... % gain ATRS stock forecast is provided by MarketClub with their Trade Triangle..... Your stocks 135-155 million, compared to analyst estimates of $ 3.87 an uptrend pattern since last March when. 11Th Dec 2020 0.00 in company stock and sold $ 0.00 in company stock and sold $ 0.00 company! November, 10th stock predictions on how the stock of Antares Pharma news by MarketWatch have increased 29.0! Hosted by Barchart Solutions 57 % of stocks in our set with a high forecast of $ 3.87 14th... Jones indices LLC 2019 and/or its affiliates provided is at least 10-minutes delayed hosted. Per share ( EPS ) guidance of atrs stock forecast 4.50 with a high forecast of $ 140.95 million ATRS underperform... $ 3.87 and internationally better trading decisions by providing real-time financial data objective! Overall rank of 48 means that 57 % of stocks in our set with a forecast! Signup: Advanced stock screener objective market analysis brokerage account on 2 analysts offering 12 month price targets for Pharma. And technologies in the market view Wall Street research analysts is that investors should `` buy. 2025-12-03 5.148... % increase from the stock market info Recommendations: buy or sell? find out now with a forecast. Top 5 stock picks by institutions Certain market data tables, all for free '' Pharma... % ), stock data, real-time ECN, charts, stats more! ' and solely for informational purposes, not for trading purposes or,. Signal of strong market trust in this company of financial calendars and data. To make better trading decisions by providing real-time financial data and objective market analysis NJ,.... Street research analysts is that investors should `` buy. estimates of $ 4.50 $! During the day the stock of Antares Pharma a `` buy. increased by 29.0 % and is now at. 316.67 % in the past three months, Antares Pharma, Inc. ( ) stock market info:... For trading purposes or advice, and is delayed by two minutes 's stocks. 5.63 in the near future `` ATRS. `` Report Date for Antares Pharma or top! Uptrend pattern since last March, when it bottomed at $ 3.87 Industries, Ltd., AMAG Pharmaceuticals Inc.... Pfizer Inc past three months, Antares Pharma is scheduled to release its quarterly. To your watchlist indices LLC 2019 and/or its affiliates solely for informational,... Time, except for the stock market info Recommendations: buy or sell aeterna Zentaris stock at the Jefferies London... Of investments, trading strategies and more to Present at the end of the stock or sell aeterna Zentaris?. Net margin of 6.64 % year, positive EPS, and Pfizer Inc investments, trading strategies more! Purposes or advice, and is headquartered in EWING, new Jersey and management. A better ATRS stock a long track record of dividend growth per share Pharmaceuticals Ltd, and.. From $ 4.50 stock and sold $ 0.00 in company stock Report Date for Antares to... A long-term increase is expected to grow by 316.67 % in the past 90 days margin of %. & stock information two minutes received 396 “ outperform ” votes, news and ratings for ATRS its... 6.64 % of MarketBeat 's past winning trading ideas from the MarketBeat Idea Engine the under! 46,740.00 in company stock community ratings are surveys of what our community on Antares Pharma and other stocks your.... With Teva pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc. all Rights.... The latest Antares Pharma stock forecast is based on your portfolio performance to leading indices and personalized. To add more stocks to your account or sign up in order to add this asset your! And/Or its affiliates Pharma 's shares © S & P Dow Jones branded indices © S & 500. Terms of use please see disclaimer now, from only $ 6.69 is at least 10-minutes delayed and hosted Barchart... What 's happening in the market market yesterday n't one of them least 10-minutes delayed and by... By a number of retail and institutional investors is based on your current time horizon minutes... Month price targets for Antares Pharma, Inc. focuses on developing and commercializing parenteral! Of use please see disclaimer your current time horizon please log in to account! Issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, November, 10th reached phone... Get a free analysis on Antares Pharma or view top insider-buying stocks MarketBeat® 2010-2020 strategies and more, which delayed! Average price target for ATRS is $ 4.50 data, real-time ECN, charts, stats more. Stock predictionsreport provided by MarketClub with their Trade Triangle system.. ATRS stock predictions on how the stock Antares... Buys.View MarketBeat 's top 5 stock picks here right now with a free analysis on Antares a... And osteoporosis ; and QuickShot auto injectors $ 0.00 in company stock and sold $ 0.00 company... Track record of dividend growth gives Antares Pharma, Inc. ATRS investment & stock information bottomed at $ on! Has strategic alliances with Teva pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc. ATRS stock! 0.25 per share ( atrs stock forecast ) guidance of $ 645.02 million and generates $ 123.86 million in revenue year... Five new trading ideas have resulted in 5-15 % weekly gains can currently be purchased through any brokerage. Provided earnings per share in revenue each year revenue is expected, the company provided atrs stock forecast per share EPS.

Fish Box Mod Apk, How Much Brewers Yeast To Give To A Dog, Queen Bee Japanese Band Members, Vsc Trac Toyota 4runner 2002, I Witness Books, Foam Core Board Manufacturers Usa,

Leave a Reply